Copyright
©2014 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Feb 7, 2014; 20(5): 1228-1237
Published online Feb 7, 2014. doi: 10.3748/wjg.v20.i5.1228
Published online Feb 7, 2014. doi: 10.3748/wjg.v20.i5.1228
Inflammatory bowel disease: An increased risk factor for neurologic complications
Germán Morís, Neurology Department, Hospital Universitario Central Asturias, Oviedo, 33006 Asturias, Spain
Author contributions: Morís G contributed to this work with conception and design, acquisition of data and interpretation of data; Morís G drafted the article and final approved of the version to be published.
Correspondence to: Germán Morís, MD, Neurology Department, Hospital Universitario Central Asturias, C/Celestino Villamil s/n, Oviedo, 33006 Asturias, Spain. gmorist@gmail.com
Telephone: +34-98-5108000 Fax: +34-98-5109479
Received: October 10, 2013
Revised: December 21, 2013
Accepted: January 3, 2014
Published online: February 7, 2014
Processing time: 132 Days and 22.5 Hours
Revised: December 21, 2013
Accepted: January 3, 2014
Published online: February 7, 2014
Processing time: 132 Days and 22.5 Hours
Core Tip
Core tip: The neurological manifestations in inflammatory bowel disease (IBD) patients are often unrecognized or underestimated. A detailed revision of the literature about the neurological manifestations in ulcerative colitis and Crohn’s disease patients is relevant to the IBD community, especially in the biologics era. Gastroenterologists should be aware of the neurologic manifestations of IBD in order to provide prevention and early treatment, which is crucial for preventing major neurologic morbidity.